BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9878456)

  • 1. Identification of domains involved in superantigenicity of streptococcal pyrogenic exotoxin F (SpeF).
    Eriksson A; Holm SE; Norgren M
    Microb Pathog; 1998 Nov; 25(5):279-90. PubMed ID: 9878456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Streptococcal DNase B is immunologically identical to superantigen SpeF but involves separate domains.
    Eriksson A; Eriksson B; Holm SE; Norgren M
    Clin Diagn Lab Immunol; 1999 Jan; 6(1):133-6. PubMed ID: 9874677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Definition of the mitogenic factor (MF) as a novel streptococcal superantigen that is different from streptococcal pyrogenic exotoxins A, B, and C.
    Toyosaki T; Yoshioka T; Tsuruta Y; Yutsudo T; Iwasaki M; Suzuki R
    Eur J Immunol; 1996 Nov; 26(11):2693-701. PubMed ID: 8921957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyrogenicity and cytokine-inducing properties of Streptococcus pyogenes superantigens: comparative study of streptococcal mitogenic exotoxin Z and pyrogenic exotoxin A.
    Müller-Alouf H; Proft T; Zollner TM; Gerlach D; Champagne E; Desreumaux P; Fitting C; Geoffroy-Fauvet C; Alouf JE; Cavaillon JM
    Infect Immun; 2001 Jun; 69(6):4141-5. PubMed ID: 11349089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for the recognition of superantigen streptococcal pyrogenic exotoxin A (SpeA1) by MHC class II molecules and T-cell receptors.
    Papageorgiou AC; Collins CM; Gutman DM; Kline JB; O'Brien SM; Tranter HS; Acharya KR
    EMBO J; 1999 Jan; 18(1):9-21. PubMed ID: 9878045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superantigenic properties of the group A streptococcal exotoxin SpeF (MF).
    Norrby-Teglund A; Newton D; Kotb M; Holm SE; Norgren M
    Infect Immun; 1994 Dec; 62(12):5227-33. PubMed ID: 7960098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning, expression, and characterization of the superantigen streptococcal pyrogenic exotoxin G from Streptococcus dysgalactiae.
    Zhao J; Hayashi T; Saarinen S; Papageorgiou AC; Kato H; Imanishi K; Kirikae T; Abe R; Uchiyama T; Miyoshi-Akiyama T
    Infect Immun; 2007 Apr; 75(4):1721-9. PubMed ID: 17283088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological and biochemical characterization of streptococcal pyrogenic exotoxins I and J (SPE-I and SPE-J) from Streptococcus pyogenes.
    Proft T; Arcus VL; Handley V; Baker EN; Fraser JD
    J Immunol; 2001 Jun; 166(11):6711-9. PubMed ID: 11359827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional characterization of streptococcal pyrogenic exotoxin J, a novel superantigen.
    McCormick JK; Pragman AA; Stolpa JC; Leung DY; Schlievert PM
    Infect Immun; 2001 Mar; 69(3):1381-8. PubMed ID: 11179302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of the streptococcal superantigen SpeI and functional role of a novel loop domain in T cell activation by group V superantigens.
    Brouillard JN; Günther S; Varma AK; Gryski I; Herfst CA; Rahman AK; Leung DY; Schlievert PM; Madrenas J; Sundberg EJ; McCormick JK
    J Mol Biol; 2007 Apr; 367(4):925-34. PubMed ID: 17303163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the interaction between the bacterial superantigen streptococcal pyrogenic exotoxin A (SpeA) and the human T-cell receptor.
    Kline JB; Collins CM
    Mol Microbiol; 1997 Apr; 24(1):191-202. PubMed ID: 9140976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of toxicity of streptococcal pyrogenic exotoxin A mutants.
    Roggiani M; Stoehr JA; Leonard BA; Schlievert PM
    Infect Immun; 1997 Jul; 65(7):2868-75. PubMed ID: 9199461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of two novel pyrogenic toxin superantigens made by an acute rheumatic fever clone of Streptococcus pyogenes associated with multiple disease outbreaks.
    Smoot LM; McCormick JK; Smoot JC; Hoe NP; Strickland I; Cole RL; Barbian KD; Earhart CA; Ohlendorf DH; Veasy LG; Hill HR; Leung DY; Schlievert PM; Musser JM
    Infect Immun; 2002 Dec; 70(12):7095-104. PubMed ID: 12438391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of streptococcal pyrogenic exotoxin C vaccine toxoids that are protective in the rabbit model of toxic shock syndrome.
    McCormick JK; Tripp TJ; Olmsted SB; Matsuka YV; Gahr PJ; Ohlendorf DH; Schlievert PM
    J Immunol; 2000 Aug; 165(4):2306-12. PubMed ID: 10925320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Streptococcal superantigen-induced expansion of human tonsil T cells leads to altered T follicular helper cell phenotype, B cell death and reduced immunoglobulin release.
    Davies FJ; Olme C; Lynskey NN; Turner CE; Sriskandan S
    Clin Exp Immunol; 2019 Jul; 197(1):83-94. PubMed ID: 30815853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superantigens and streptococcal toxic shock syndrome.
    Proft T; Sriskandan S; Yang L; Fraser JD
    Emerg Infect Dis; 2003 Oct; 9(10):1211-8. PubMed ID: 14609454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA class II polymorphisms determine responses to bacterial superantigens.
    Llewelyn M; Sriskandan S; Peakman M; Ambrozak DR; Douek DC; Kwok WW; Cohen J; Altmann DM
    J Immunol; 2004 Feb; 172(3):1719-26. PubMed ID: 14734754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Streptococcal superantigen, mitogenic factor, and pyrogenic exotoxin B expressed by Streptococcus pyogenes. Structure and function.
    Musser JM
    Prep Biochem Biotechnol; 1997; 27(2-3):143-72. PubMed ID: 9292924
    [No Abstract]   [Full Text] [Related]  

  • 19. Streptococcus pyogenes: Insight into the function of the streptococcal superantigens.
    Sriskandan S; Faulkner L; Hopkins P
    Int J Biochem Cell Biol; 2007; 39(1):12-9. PubMed ID: 17029999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitogenicity of M5 protein extracted from Streptococcus pyogenes cells is due to streptococcal pyrogenic exotoxin C and mitogenic factor MF.
    Schmidt KH; Gerlach D; Wollweber L; Reichardt W; Mann K; Ozegowski JH; Fleischer B
    Infect Immun; 1995 Dec; 63(12):4569-75. PubMed ID: 7591107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.